Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Risk of community-acquired pneumonia after acid-suppressive drugs

Nature Clinical Practice Gastroenterology & Hepatology volume 2, pages 72–73 (2005)Cite this article

boxed-textLaheij RJF et al. (2004) Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 292: 1955–1960

When prescribing acid-suppressive drugs, clinicians should consider that 1 of every 200–500 patients treated with these drugs might develop community-acquired pneumonia

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Laine L et al. (2000) Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors. Aliment Pharmacol Ther 14: 651–668

    Article  CAS  Google Scholar 

  2. Marcuard SP et al. (1994) Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin B12). Ann Intern Med 120: 211–215

    Article  CAS  Google Scholar 

  3. Verdu E et al. (1994) Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds. Gut 35: 455–460

    Article  CAS  Google Scholar 

  4. Driks MR et al. (1987) Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. N Engl J Med 26: 1376–1382

    Article  Google Scholar 

  5. Cook D et al. (1998) A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med 338: 791–797

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Minal Chande, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Chief of the Division of Gastroenterology, Dallas Veterans Affairs Medical Center and Professor of Medicine at University of Texas Southwestern Medical Center, Dallas, Texas, USA

    Stuart J Spechler

Authors
  1. Stuart J Spechler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stuart J Spechler.

Ethics declarations

Competing interests

Stuart Spechler receives grant support from AstraZeneca and Novartis. He is also on the speaker's bureau for AstraZeneca, TAP and Janssen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spechler, S. Risk of community-acquired pneumonia after acid-suppressive drugs. Nat Rev Gastroenterol Hepatol 2, 72–73 (2005). https://doi.org/10.1038/ncpgasthep0093

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0093

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing